GoKawiilHims launches testosterone replacement therapy service for men
Hims, the publicly traded telehealth company, has launched a testosterone replacement therapy service for cisgender men, offering two injectable options and an oral pill after an at-home blood test. Peter Stahl, a urologist and senior VP of men's health at Hims, says the company aims to test as many men as possible for testosterone deficiency. Hims began in 2017 selling erectile dysfunction drugs and has since expanded into women's health, now serving 2.9 million customers.